Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
Almudena García-Ortiz, Yaiza Rodríguez‐García, Jessica Encinas, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 217-217
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

Metal-Phenolic Network-Enabled Lactic Acid Consumption Reverses Immunosuppressive Tumor Microenvironment for Sonodynamic Therapy
Zhan Zhang, Bei Li, Lisi Xie, et al.
ACS Nano (2021) Vol. 15, Iss. 10, pp. 16934-16945
Closed Access | Times Cited: 129
Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma
Muthulekha Swamydas, Elena V. Murphy, James J. Ignatz-Hoover, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 82
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies
Marco Ruella, Felix Korell, Patrizia Porazzi, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 976-995
Open Access | Times Cited: 53
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
Emma Verheye, Jesús Bravo Melgar, Sofie Deschoemaeker, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 904-904
Open Access | Times Cited: 38
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment
Hannah Egan, Oliver Treacy, Kevin Lynch, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112475-112475
Open Access | Times Cited: 37
The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells
Claudia Giannotta, Federica Autino, Massimo Massaia
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 24
The Role of Tumor-Associated Macrophages in Hematologic Malignancies
Emanuele Cencini, Alberto Fabbri, Anna Sicuranza, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3597-3597
Open Access | Times Cited: 44
Pathogenesis and treatment of multiple myeloma
Peipei Yang, Ying Qu, Mengyao Wang, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 28
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
Qiang Cao, Xinyan Wu, Qi Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
Kamlesh Bisht, Taro Fukao, Marielle Chiron, et al.
Cancer Medicine (2023) Vol. 12, Iss. 20, pp. 20332-20352
Open Access | Times Cited: 21
Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma
Chunmei Kuang, Meijuan Xia, Gang An, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: Impact on disease progression
Daniel García‐Sánchez, Alberto González-González, Ana Alfonso-Fernández, et al.
World Journal of Stem Cells (2023) Vol. 15, Iss. 5, pp. 421-437
Open Access | Times Cited: 18
Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease
Minghao Dang, Guangchun Han, Hans C. Lee, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1032-1047.e4
Open Access | Times Cited: 18
Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy
Brian M. Russell, David Avigan
International Journal of Hematology (2023) Vol. 117, Iss. 5, pp. 652-659
Open Access | Times Cited: 17
Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
Fatih M. Uckun
Cancers (2021) Vol. 13, Iss. 9, pp. 2018-2018
Open Access | Times Cited: 40
Natural Killer Cells in the Malignant Niche of Multiple Myeloma
Ondrej Venglár, Julio Rodriguez Bagó, Benjamin Motais, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 23
Molecular and immunological mechanisms of clonal evolution in multiple myeloma
Stefan Förster, Ramin Radpour, Adrian F. Ochsenbein
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno‐microenvironment in multiple myeloma
Alessandro Barbato, Cesarina Giallongo, Sebastiano Giallongo, et al.
Cell Proliferation (2023) Vol. 56, Iss. 4
Open Access | Times Cited: 14
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications
Emanuele Cencini, Anna Sicuranza, Sara Ciofini, et al.
Current Oncology (2023) Vol. 30, Iss. 7, pp. 6111-6133
Open Access | Times Cited: 14
Perspectives on the Treatment of Multiple Myeloma
Abdul Rafae, Frits van Rhee, Samer Al Hadidi
The Oncologist (2023) Vol. 29, Iss. 3, pp. 200-212
Open Access | Times Cited: 14
Cell indices as predictors of progression-free survival in multiple myeloma: a retrospective cohort study
Viet Trung Han, Minh Phuong Vu, Phuong Pham, et al.
ONCOLOGIE (2025)
Closed Access
Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora’s Box of Multiple Myeloma
Juan‐José Garcés, Jesús F. San Miguel, Bruno Paiva
Cancers (2022) Vol. 14, Iss. 6, pp. 1430-1430
Open Access | Times Cited: 19
Therapeutic efficacy of caffeic acid phenethyl ester in cancer therapy: An updated review
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 1, pp. 201-216
Closed Access | Times Cited: 12
An overview of multiple myeloma: A monoclonal plasma cell malignancy’s diagnosis, management, and treatment modalities
Maisa Siddiq Abduh
Saudi Journal of Biological Sciences (2023) Vol. 31, Iss. 2, pp. 103920-103920
Open Access | Times Cited: 12
Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma
Shamila D. Alipoor, Hong Chang
Cells (2023) Vol. 12, Iss. 7, pp. 1030-1030
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top